Biotechnology & Medical Research - Industry
OncoSec Medical's activity chart (see below) currently has 10 price targets and 9 ratings on display.
Analysts' price targets on this stock were met 20% of the time, taking 212.33 days on average.
Most recent stock forecast was given by JASON KOLBERT from DAWSON JAMES on 17-Mar-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Jul-2020
$220
4 years 8 months 4 days ago
(17-Mar-2022)
0/1 (0%)
$147.4 (203.03%)
Buy Since 31-Jul-2019
$12
$6
5 years 7 months 27 days ago
(25-Mar-2021)
2/2 (100%)
$-105.7 (-89.80%)
872
Buy Since 15-Oct-2018
$153.85
6 years 11 months 5 days ago
(15-Dec-2019)
1/5 (20%)
$112.93 (275.98%)
402
Hold Since 06-Nov-2018
$220
$1320
8 years 14 days ago
(06-Nov-2018)
0/2 (0%)
$30.8 (16.28%)
What is ONCS (OncoSec Medical) average time for price targets to be met?
Which analyst most recently updated their price target on ONCS (OncoSec Medical)?
Which analyst has the lowest performance score on ONCS (OncoSec Medical) with a proven track record?
Which analyst has the most public recommendations on ONCS (OncoSec Medical)?
Which analyst is the currently most bullish on ONCS (OncoSec Medical)?
Which analyst is the currently most reserved on ONCS (OncoSec Medical)?